Percheron Therapeutics LimitedASX: PER

Phase II DMD clinical trial on track for dosing completion

Jul 24, 2019 at 4:25 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment